Your browser doesn't support javascript.
loading
AIM2 regulates anti-tumor immunity and is a viable therapeutic target for melanoma.
Fukuda, Keitaro; Okamura, Ken; Riding, Rebecca L; Fan, Xueli; Afshari, Khashayar; Haddadi, Nazgol-Sadat; McCauley, Sean M; Guney, Mehmet H; Luban, Jeremy; Funakoshi, Takeru; Yaguchi, Tomonori; Kawakami, Yutaka; Khvorova, Anastasia; Fitzgerald, Katherine A; Harris, John E.
Afiliação
  • Fukuda K; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Okamura K; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Riding RL; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Fan X; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Afshari K; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Haddadi NS; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • McCauley SM; Department of Dermatology, University of Massachusetts Medical School, Worcester, MA.
  • Guney MH; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.
  • Luban J; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.
  • Funakoshi T; Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA.
  • Yaguchi T; Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA.
  • Kawakami Y; Department of Dermatology, Keio University School of Medicine, Tokyo, Japan.
  • Khvorova A; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Fitzgerald KA; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Harris JE; RNA Therapeutics Institute, University of Massachusetts Medical School, Worcester, MA.
J Exp Med ; 218(9)2021 09 06.
Article em En | MEDLINE | ID: mdl-34325468
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Vacinas Anticâncer / Proteínas de Ligação a DNA / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Melanoma Experimental / Vacinas Anticâncer / Proteínas de Ligação a DNA / Melanoma Idioma: En Ano de publicação: 2021 Tipo de documento: Article